THE PROGRESSION OF CISPLATIN-INDUCED TUBULOINTERSTITIAL NEPHROPATHY IN RATS

被引:13
|
作者
MARCUSSEN, N
JACOBSEN, NO
机构
[1] AARHUS UNIV,AARHUS KOMMUNE HOSP,INST PATHOL,STEREOL RES LAB,DK-8000 AARHUS,DENMARK
[2] DANISH CANC SOC,DEPT EXPTL CLIN ONCOL,AARHUS,DENMARK
关键词
ATUBULAR GLOMERULI; ENZYME HISTOCHEMISTRY; GLOMERULAR VOLUME; MORPHOMETRY; STEREOLOGY;
D O I
10.1111/j.1699-0463.1992.tb00869.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that administration of cisplatin to rats leads to chronic nephropathy with many atubular glomeruli. Using unbiased stereological and histochemical methods our purpose was to investigate the progression of renal structural changes, specifically the events preceding and following the formation of atubular glomeruli in rats after increasing total doses of cisplatin. After administration of cisplatin (2 mg/kg body weight i.p. once weekly) the animals were sacrificed 10 days, three, six, 10 and 20 weeks later. After 4 mg/kg the distal part of most proximal S3 segments appeared necrotic with a negative reaction for enzymes characteristic of brush border and mitochondria. After larger doses, atrophy (and possibly necrosis) was observed in clusters of cortical proximal and distal nephron segments corresponding to an increasing amount of non-functioning nephrons. Hypertrophy/hyperplasia of remaining uninjured nephrons and collecting ducts was observed. The stereological investigations showed an increasing number of atubular glomeruli with open capillaries or glomeruli connected to atrophic tubules with the total dose of cisplatin (30% and 40%, respectively, after 20 mg/kg). The percentage of glomeruli with damaged tubules was significantly higher in the juxtamedullary cortex compared with the superficial cortex. Sclerotic glomeruli were not observed. The findings suggest that a toxic destruction of most S3 segments leads to atrophy or disappearance of the corresponding nephrons with formation of atubular glomeruli, and that the remaining hypertrophic nephrons are connected to the few surviving or regenerated S3 segments.
引用
收藏
页码:256 / 268
页数:13
相关论文
共 50 条
  • [32] Pregabalin reduces cisplatin-induced mechanical allodynia in rats
    Seto, Yoshihiro
    Takase, Miyuki
    Tsuji, Yasuhiro
    To, Hideto
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 134 (03) : 175 - 180
  • [33] Effect of Epigallocatechin Gallate on Cisplatin-Induced Nephrotoxicity in Rats
    Timurkaan, Mustafa
    Demir, Mustafa
    Gomleksiz, Muhammet Ridvan
    Ozercan, Ibrahim Halil
    Sahin, Kazim
    Dogukan, Ayhan
    TURKISH JOURNAL OF NEPHROLOGY, 2021, 30 (04): : 262 - 268
  • [34] Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats
    Orhan, B
    Yalcin, S
    Nurlu, G
    Zeybek, D
    Muftuoglu, S
    MEDICAL ONCOLOGY, 2004, 21 (02) : 197 - 203
  • [35] Azadirachta indica attenuates cisplatin-induced neurotoxicity in rats
    Moneim, Ahmed Esmat Abdel
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (03) : 316 - 321
  • [36] Attenuation of cisplatin-induced nephrotoxicity in rats using zerumbone
    Ibrahim, Mohamed Yousif
    Abdul, Ahmad Bustamam Hj
    Ibrahim, Tengku Azmi Tengku
    AbdelWahab, Siddig Ibrahim
    Elhassan, Manal Mohamed
    Mohan, Syam
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (28): : 4434 - 4441
  • [37] Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats
    Elberry, Ahmed A.
    Refaie, Shereen M.
    Kamel, Mohamed W.
    Ali, Tarek M.
    Darwish, Hatem
    Ashourg, Osama M.
    ANNALS OF SAUDI MEDICINE, 2013, 33 (01) : 57 - 62
  • [38] Mitigation of cisplatin-induced peripheral neuropathy by canagliflozin in rats
    Ahmed A. Abdelsameea
    Soad L. Kabil
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2018, 391 : 945 - 952
  • [39] Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats
    Ateyya, Hayam
    Yosef, Hala
    Nader, Manar A.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (02) : 225 - 230
  • [40] Pemirolast reduces cisplatin-induced kaolin intake in rats
    Tatsushima, Yoko
    Egashira, Nobuaki
    Matsushita, Naohiro
    Kurobe, Kentaro
    Kawashiri, Takehiro
    Yano, Takahisa
    Oishi, Ryozo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 661 (1-3) : 57 - 62